Vanguard Personalized Indexing Management LLC Reduces Position in CVS Health Co. (NYSE:CVS)

Vanguard Personalized Indexing Management LLC trimmed its holdings in CVS Health Co. (NYSE:CVS) by 11.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,722 shares of the pharmacy operator’s stock after selling 12,912 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in CVS Health were worth $5,771,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in CVS. Wedmont Private Capital lifted its position in CVS Health by 0.8% during the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after buying an additional 146 shares in the last quarter. Moody National Bank Trust Division raised its holdings in shares of CVS Health by 0.7% during the 1st quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock worth $1,776,000 after acquiring an additional 150 shares during the period. Landmark Financial Advisors LLC boosted its position in shares of CVS Health by 3.8% during the 4th quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after acquiring an additional 153 shares during the last quarter. Garland Capital Management Inc. increased its position in CVS Health by 0.3% during the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after purchasing an additional 160 shares during the last quarter. Finally, Sepio Capital LP raised its stake in CVS Health by 1.7% during the fourth quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock worth $782,000 after purchasing an additional 163 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CVS shares. Wells Fargo & Company increased their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Royal Bank of Canada reissued an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Monday. Baird R W raised shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Finally, JPMorgan Chase & Co. reduced their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Eleven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Stock Up 1.0 %

Shares of NYSE CVS opened at $58.42 on Thursday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The stock has a market cap of $73.34 billion, a P/E ratio of 10.27, a PEG ratio of 0.79 and a beta of 0.53. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The business’s fifty day simple moving average is $58.33 and its 200-day simple moving average is $62.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter last year, the business posted $2.21 EPS. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. As a group, equities analysts predict that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.55%. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.